logo
Skin swabs may help detect Parkinson's years before symptoms appear

Skin swabs may help detect Parkinson's years before symptoms appear

There is currently no cure for Parkinson's disease, nor are there specific tests for early diagnosis. A new study has identified a way to detect the condition before symptoms appear through the use of skin swabs via sebum and smell. The swabs could offer a noninvasive way to help diagnose Parkinson's disease in people who have not yet developed symptoms. According to the Parkinson's Foundation, more than 10 million people around the world are living with Parkinson's disease — a neurological disease that negatively impacts a person's movement and speech abilities.There is currently no cure for Parkinson's disease. Although right now there are no specific tests to help diagnose the condition, identifying warning signs of Parkinson's disease as early as possible is critical in helping to slow disease progression. 'Current clinical diagnosis is too late as disease has progressed a lot,' Drupad K. Trivedi, PhD, lecturer in analytical and measurement science at the University of Manchester, told Medical News Today. Trivedi is the corresponding author of a new study recently published in the journal npj Parkinson's Disease that has identified a way to detect the condition before symptoms appear through the use of skin swabs. 'Smelling' signs of Parkinson's diseaseFor this study, scientists focused on testing study participants by using skin swabs of their sebum — an oily substance naturally produced by the skin's sebaceous glands.Through the skin swabs, Trivedi said they were able to detect volatile organic compounds (VOCs) in the sebum. Different VOCs have a distinct smell, which is what helps make each person's body odor unique. 'We have found a few compounds that are expressed differently in people with Parkinson's disease compared to healthy controls as well as those who had REM sleep behavior disorder. A test that is a simple skin swab can potentially be the first test to detect Parkinson's before all the clinical signs start appearing.' — Drupad K. Trivedi, PhDThis study is an extension of two previous studies conducted by Trivedi and his team. The first study in March 2019 identified the presence of VOC biomarkers in the sebum of people with Parkinson's disease that also has a distinct smell. A second study in February 2021 that found a differential VOC profile between participants with Parkinson's disease and controls when analyzing their sebum. All of this research was reportedly inspired by Joy Milne, a research associate at the University of Manchester, who has a condition called hyperosmia, giving her an extremely strong sense of smell. In 2015, it was reported that Milne was able to 'smell' Parkinson's disease on her husband about six years before he received his diagnosis.The concept of 'smelling' Parkinson's disease was further validated in a study recently published in the Journal of Parkinson's Disease — for which Trivedi was also part of the research team — that found trained dogs could detect an odor on skin swabs to detect Parkinson's disease. Sebum compound levels may indicate Parkinson's diseaseResearchers recruited 83 study participants. Of this number, 46 had a Parkinson's disease diagnosis, 28 were healthy controls, and nine had isolated REM Sleep Behavior Disorder (iRBD), which is considered to be an early warning sign of Parkinson's disease. Upon analysis, Trivedi and his team found that 55 significant features in the sebum that varied between the groups, and those with iRBD had levels in between those with Parkinson's disease and the healthy controls.'There were 55 features that showed levels for iRBD between healthy and Parkinson's disease,' Trivedi detailed. 'iRBD is one of the prodromal symptoms of Parkinson's disease. This means a good proportion of individuals suffering from iRBD may develop Parkinson's disease in the next decade or more. The intermediate level indicates a progression from control to iRDB to Parkinson's disease.' 'By early detection, we will be able to triage and offer advanced clinical tests, specialist support for confirmatory diagnosis without relying on physical symptoms to appear,' he continued. 'It also creates a potential to develop disease-modifying therapies in the future.' 'Next steps are to quantify these observed compounds in Parkinson's disease and iRBD, and also validate these findings in a long-term prospective study of [a] bigger iRBD cohort,' Trivedi added. Sebum VOCs may also help map Parkinson's progressionAdditionally, Trivedi collected sebum samples from people with Parkinson's disease over a three-year period. From these samples, he was able to find sebum compound patterns that suggest this method may also be used to map disease progression. 'This indicates that molecules we see on (the) skin surface may indicate progression of Parkinson's disease — it is a progressive disease with no cure,' he explained. 'A sudden, rapid progression could be monitored in future using such markers on [the] skin surface. There is also a potential to monitor [the] efficacy of treatment by such an approach.'Possible noninvasive tool for diagnosing presymptomatic Parkinson'sMNT also spoke with Rocco DiPaola, MD, a neurologist and movement disorder specialist at Hackensack Meridian Neuroscience Institute at Jersey Shore University Medical Center in New Jersey, about this study. DiPaola commented that this study's results would offer a noninvasive tool for potentially diagnosing presymptomatic Parkinson's disease. 'While there are currently no treatments that prevent or slow the progression of disease, as these treatments become available, it will be important to identify those at risk prior to symptom onset,' he continued. 'Further studies on a larger scale to further determine validity of results as well as a means to have this available as a standardized test. Although not specific to this study, it would be important to continue to find ways to diagnose Parkinson's disease prior to symptom onset.'
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Suffolk care provider rated as inadequate by watchdog
Suffolk care provider rated as inadequate by watchdog

BBC News

time21 minutes ago

  • BBC News

Suffolk care provider rated as inadequate by watchdog

A care provider that looks after people with dementia, mental health conditions and physical disabilities has been rated inadequate by a health watchdog. Hearts of Care Agency, based in Ipswich, Suffolk, was placed into special measures by the Care Quality Commission (CQC).The CQC said the firm, which provides cares for 16 people in their own home, was inadequate for being safe, effective, responsive and well-led. Hearts of Care Agency said it was "disappointed" by the CQC's rating but would "learn from our mistakes". The firm being placed in special measures means the business will be closely monitored and a timeframe has been set out for improvements to be made, the CQC said. A report, which was published by the watchdog, stated that a condition was placed on Hearts of Care Agency when it registered with the CQC to not provide services for autistic adults or adults with a learning however, found that these services were being carried CQC inspection, which was carried out in May, also found that the firm was supporting children and younger adults with personal care when it was not registered to do so. Poor leadership Hazel Roberts, the CQC deputy director of operations in the East of England, said: "When we inspected the Hearts of Care Agency, we were concerned to find the service wasn't always meeting people's needs safely, because leaders weren't managing the service well."Leaders had not registered with CQC to care for children, young people, autistic people, or people with a learning disability, but were providing care to them anyways. "We were deeply concerned to find staff didn't always understand how best to support their individual needs or respect their rights." Mark Elvidge, the director of Hearts of Care Agency, said: "Following our recent assessment Hearts of Care Agency are extremely disappointed with our rating of inadequate. "We have happy clients and happy staff and view this rating as harsh and unfair."However, we will not be complacent about our failings. As a director, I take full responsibility, but I can assure our clients, staff, and public we will learn from our mistakes and shortcomings."He said the firm has a plan in place to make improvements before the next inspection in August. Follow Suffolk news on BBC Sounds, Facebook, Instagram and X.

Medical trial for penis cancer 'gave me two more years'
Medical trial for penis cancer 'gave me two more years'

BBC News

time23 minutes ago

  • BBC News

Medical trial for penis cancer 'gave me two more years'

A man who was the first to take part in a medical trial for penile cancer says it may have extended his life by two years. Eddie Baker, 83, was given immunotherapy alongside the usual treatment of chemotherapy as part of the clinical trial, named treatment was found to have extended the predicted lifespans of more than half of the participants in the study, which was carried out by University Hospitals Bristol and Weston NHS Foundation Baker, from Yate, South Gloucestershire, said: "All I can say is, it is the most wonderful thing that ever happened to me because I know if I hadn't had that, I would not be on this planet to this day." Mr Baker told the BBC his cancer had been caught late because it took over a year for him to come forward with his symptoms. The NHS says symptoms can include bleeding, a rash, a lump or growth, and a change in skin colour."It didn't look very good," Mr Baker said. "The actual swelling got bigger and bigger and then I was trying to get somewhere to get my life sorted out and find out what it was. It was too late."He had to have an amputation and has been left with incurable cancer. Consultant oncologist and chief investigator of the EPIC study, Professor Amit Bahl, said the stigma around such symptoms often leads to late said: "In cancers like these, there is no support system, you can't go out and talk about it because most patients have never heard you can get cancer in the penis. "If you ask ladies, they have heard about cancer in the cervix, in the vagina, but cancer in the penis never gets talked about."The immunotherapy treatment used in the trial is not available on the NHS, but Professor Bahl is applying to the Cancer Drugs Fund to pay for the small number patients who may benefit. Using immunotherapy to treat cancer is still considered by doctors to be a relatively new more than 60 per cent of the patients in the trial, who all had advanced penile cancer, were found to have had a clinical these patients, predicted lifespans increased to 15 months on Bahl said: "Our aim is to improve outcomes in this rare cancer, which has limited treatment options."Penile cancer can be a very aggressive disease, but this study shows we might be able to give men a little more time."Penile cancer is rare, and it usually presents externally first, so when patients are diagnosed, early treatments which can cure the cancer are possible."The trial has proved so successful that Professor Bahl is now planning to start another trial to give immunotherapy at an earlier stage of the disease, in the hope that it will improve cure rates.

Woking NHS nurse campaigns for 'urgent' train ticket reform
Woking NHS nurse campaigns for 'urgent' train ticket reform

BBC News

time23 minutes ago

  • BBC News

Woking NHS nurse campaigns for 'urgent' train ticket reform

A Surrey NHS worker has launched a campaign calling for urgent train ticket reform after revealing she spends more than £200 a month commuting to her job at a London Arias moved from London to Woking a year ago to save on rent and said her train travel costs remains high despite using a discount Flexi Season campaign on has collected more than 24,100 signatures and she is urging rail bosses to introduce 24-hour train tickets.A Department for Transport (DfT) spokesperson said: "While we are not planning to introduce 24-hour return tickets, we are overhauling the complex fares system to make rail travel simpler and more flexible for passengers." Ms Arias, who works as a paediatric cardiac intensive care nurse at Great Ormond Street Hospital, told the Local Democracy Reporting Service she sometimes "regrets moving to Woking".She added she works 12-hour shifts, often overnight, and purchases two tickets for each shift, one to travel in and another to get home the next morning as existing train tickets expire at 04:29 BST."When we work a night shift, we don't have a break and then we have to pay for another ticket. It's just not fair," she there are other hospitals in Surrey, Ms Arias said she never wanted to leave her current job. 'Expensive and inflexible' "Working at Great Ormond Street Hospital is a great sense of achievement," she added. "It's the best thing I've ever done."Originally from Spain, Ms Arias moved to the UK 13 years ago and said she was "shocked" by how expensive and "inflexible" British transport added that in Madrid, commuters could purchase transport passes for bus, train and rail for £70 a month. Another campaign which Ms Arias started was a petition for an NHS railcard which has reached more than 3,000 signatures on the House of Commons DfT spokesperson added: "We've already delivered ticketing innovations such as contactless pay as you go to additional stations in Surrey this year. "This gives passengers the best value ticket for their journey, with additional stations expected to get the technology soon."

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store